Roche & Herceptin Licence Application

Roche & Herceptin Licence Application

Roche & Herceptin Licence Application I emailed Roche on Monday to ask how the licence application was progressing. Here’s the reply:

"Thank you for your enquiry regarding the licence application for Herceptin (trastuzumab) in the treatment of early breast cancer.

As you correctly say, Roche stated that it will apply for a licence during Q1 2006 - this means at some point from January to March 2006. We are on track with this submission. We cannot give you the exact date as that is company confidential information at the present time."